Faegre Drinker Biddle & Reath LLP, a Delaware limited liability partnership | This website contains attorney advertising.

Overview

Clinical research institutions, universities and academic medical centers, pharmaceutical companies, medical device manufacturers, and other health and life sciences industry organizations are focused on protecting and leveraging their investments in research, development and innovation. We provide critical counseling to help preserve your assets, mitigate regulatory risk and get your products to market as expediently as possible. From clinical trials and product design to premarket approval and product launch, our team of attorneys and other professionals guides you in carefully crafting clinical trial, licensing, research and development, and other agreements; obtaining appropriate patents or other intellectual property protection; obtaining FDA and other regulatory approvals; addressing reimbursement strategies; and preparing for product liability defenses. We help you take advantage of federal tax exemptions, strategically change clinical trial processes or product designs, and conduct evidence-based advocacy to enhance federal support for areas of distinction. We are recognized for our work with clients in the areas of orphan drugs, patient-focused drug development, pediatrics and Alzheimer’s disease, among many others, and work with you to develop and win approval of treatments and medications that address some of today’s most pressing, unmet needs. We have the experience to help bring innovation to the industry and, most importantly, to patients.

Insights & Events

Latest

Press Release May 2025

Faegre Drinker Grows Life Sciences Consulting Team With Nationally Recognized Patient Experience Researcher Holly Peay, PhD

2 min read  
Media Mentions May 2025

Barrett Tenbarge Provides Insights on FDA Staffing Cuts for Chemical & Engineering News

1 min read  
Published Articles May 2025

The Booming Business of Botox: Legal Considerations for Medical Spas

2 min read  
Updates May 2025

FDA Identifies Data Quality and Study Conduct Concerns With Raptim Research and Requires Sponsors to Submit Replacement Study Data

Reminder of Importance of Adequately Vetting Contract Research Organizations
5 min read  
May 2025

The Hidden Dangers of Alternative Funding Programs

1 min read  
Press Release May 2025

Faegre Drinker Welcomes Former Senate HELP Committee General Counsel Barrett Tenbarge to Government and Regulatory Group

3 min read  
Speaking Engagement Recap March 12, 2025

The Current State of Pediatric Research: Challenges, Opportunities and Action

Society for Pediatric Research Advocacy Committee
1 min read  
Updates February 2025

A Deeper Dive Into the Making America Healthy Again Commission’s Executive Order and Its Implications

While Some Elements Lie Within the Mainstream, Others Are Cause for Concern
5 min read  
Media Mentions February 2025

Tricia Beckmann Discusses Federal Oversight of Medicare Brokers With Law360

1 min read  
Speaking Engagement Recap February 12, 2025

Evaluating Compliance and Ethics Programs in Senior Living and Care

LeadingAge Minnesota 2025 Institute & Expo
1 min read  

Related Legal Services